K050613 is an FDA 510(k) clearance for the QUANTIA BETA-2 MICROGLOBULIN. This device is classified as a System, Test, Beta-2-microglobulin Immunological (Class II - Special Controls, product code JZG).
Submitted by Biokit, S.A. (Barcelona, ES). The FDA issued a Cleared decision on August 16, 2005, 159 days after receiving the submission on March 10, 2005.
This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5630.
| 510(k) Number | K050613 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | March 10, 2005 |
| Decision Date | August 16, 2005 |
| Days to Decision | 159 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | JZG — System, Test, Beta-2-microglobulin Immunological |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 866.5630 |